Indian Drug Manufacturers Association Organises Pharma Live Expo & Summit
Ignites the future of pharma industry
The Pharma Live Expo & Summit was recently organised by the Indian Drug Manufacturers’ Association. A kaleidoscope of vibrant booths showcased the latest pharmaceutical aces, from potent APIs to sleek packaging machinery. 20,000 pharma professionals participated in the event.
The Summit was inaugurated by Dr Arunish Chawla, Dept. of Pharmaceuticals, Government of India. Present on the occasion were Ajit Singh, Chairman, Associated Capsules Group Worldwide; Abhimanyu Kale, Commissioner, FDA, Maharashtra; Dr HG Koshia, Commissioner, Food & Drugs Control Administration, Gujarat; Dr Viranchi Shah, National President, IDMA and Director, Saga Lifesciences; Chirag Doshi, Chairman, Pharma Live Expo; Shobhit Deputy Drugs Controller, FDA, Madhya Pradesh; Jayant Kumar, Dy Drugs Controller, CDSCO; Ashish Chauhan, Director, Bluetech Media; Eddy Wardoyo, Consul General, Republic of Indonesia; Raj Kumar Sharma, Founder President & CEO, Indo Latin American Chamber of Commerce; Shereef Rahuman, Managing Director Icexpo Consults, Dubai and Dr George A Patani, Vice President (Western Region), IDMA & Director, INGA Labs.
“India’s pharma and med-tech industries are on a powerful trajectory, fuelled by the government’s two-pronged approach: targeted financial incentives and strategic policy frameworks” mentioned Dr Chawla.
He highlighted initiatives like bulk drug and medical device perk schemes, common facility support, and a dedicated policy framework presently mapping the value chain across tariffs and GST to optimise tax structures and incentivise domestic value addition. He further emphasised on the ongoing reform of existing schemes to ensure their effectiveness in meeting industry needs.
“Knowledge is power, and IDMA is committed to empowering the Indian pharma industry” declared Daara Patel, Secretary General, IDMA. He pointed to their strong network of “national and international speakers, including partners like The United States Pharmacopeia (USP).”
The delegates from countries include Malaysia, Indonesia, Taiwan, Ghana, Uganda, Angola, Sri Lanka, Ethiopia, Swaziland, Slovak Republic, Australia, Madagascar, Chile, Somalia, Nepal, Rwanda, the UK, the US, Saudi Arabia, Azerbaijan, Brazil, Philippines, Nigeria, Barbados, Myanmar, Germany, the UAE.
